[Management of cardiac implantable electronic devices in cancer patients undergoing radiotherapy. An Italian Association of Hospital Cardiologists (ANMCO) statement] [0.03%]
[癌症患者接受放射治疗时的心脏植入式电子装置的管理。意大利医院 cardiologists协会(ANMCO)声明]
Maria Laura Canale,Carlo Pignalberi,Stefano Oliva et al.
Maria Laura Canale et al.
A systematic and multidisciplinary approach is needed to manage cancer patients with a cardiac implantable electronic device undergoing radiation therapy. We report a statement from the Italian Association of Hospital Cardiologists (ANMCO) ...
Annita Bava,Maria Rosaria Giuffrè,Stefano Postorino et al.
Annita Bava et al.
We describe the case of a 75-year-old hypertensive patient who comes to the emergency room for an infero-postero-lateral myocardial infarction. The entry echocardiogram showed a rounded formation with mixed echogenicity (maximum transverse ...
[Real-world triglyceride levels in secondary prevention: insights from the JET-LDL registry] [0.03%]
日本JET-LDL登记库中二级预防患者的真实甘油三酯水平分布及心血管风险评分分类
Francesco Maria Sparasci,Luca Raone,Alessia Currao et al.
Francesco Maria Sparasci et al.
Background: Hypertriglyceridemia is a common finding in patients with coronary artery disease (CAD), contributing to the residual cardiovascular risk in this population. In CAD patients with persistently elevated triglyce...
Eugenio Santoro
Eugenio Santoro
Maria Teresa Manes,Simona Giubilato,Maura Francese et al.
Maria Teresa Manes et al.
The escalation in demand for digital health services, particularly highlighted by recent global health crises, has emphasized the significance of eHealth literacy (eHL). This concept encompasses the skills necessary to effectively search fo...
[Win ratio, a new technique for the analysis of multiple events in clinical trials] [0.03%]
[胜率：临床试验中分析多个事件的新方法]
Paolo Verdecchia,Fabio Angeli,Gianpaolo Reboldi
Paolo Verdecchia
The win ratio is a relatively recent statistical technique introduced with the aim of better managing the analysis of clinical trials involving more than one clinical event as an endpoint in the evaluation of a treatment. The calculation of...
[Surgical and percutaneous treatment of hypertrophic obstructive cardiomyopathy: state-of-the-art review] [0.03%]
肥厚型梗阻性心肌病的外科和经皮治疗：现状分析
Maria Sabrina Ferrante,Calogera Pisano,Giuseppe Maria Raffa et al.
Maria Sabrina Ferrante et al.
Hypertrophic cardiomyopathy is a heterogeneous and complex disease. It is an autosomal dominant genetic disease caused by a missense mutation in one of at least 12 genes that code for cardiac sarcomere proteins. There are various approaches...
[Kidney protection: role of sodium-glucose co-transporter 2 inhibitors and finerenone] [0.03%]
肾脏保护：钠葡萄糖共转运体2抑制剂和非奈利酮的作用
Manuela Benvenuto,Emilia D&#x;Elia,Marco Cittar et al.
Manuela Benvenuto et al.
Chronic kidney disease, diabetes mellitus and heart failure represent three chronic conditions closely linked to each other from a pathophysiological and prognostic point of view. This link has led to an ever-increasing emphasis in recent y...
Simona Giubilato,Leonardo De Luca
Simona Giubilato
Despite the effectiveness of statins in reducing cardiovascular events and slowing the progression of coronary atherosclerosis, significant residual cardiovascular risk persists. In the REDUCE-IT trial, icosapent ethyl (IPE), a highly purif...
[After the ISCHEMIA trial and the new guidelines, does it still make sense to search for myocardial ischemia? When should a patient with chronic coronary syndrome be revascularized?] [0.03%]
ISCHEMIA试验和新指南之后，慢性冠脉综合征患者的缺血筛查及血运重建指征发生了哪些变化？
Stefano Urbinati
Stefano Urbinati
The ISCHEMIA study enrolled patients with chronic coronary syndrome, moderate-to-severe myocardial ischemia, and critical coronary stenosis, demonstrating that coronary revascularization is not superior to optimized medical therapy in a pop...